PwC Behind the Numbers 2027: Medical Cost Trend Hits 9%

Bypaulgruensfelder
BETAPrivate preview — this site is actively being built.
PwC June 11, 2026
Read Full Article →
AI-Generated Summary

Commercial medical cost trend is projected to reach 9% in 2027 — the highest in 17 years — according to PwC’s Behind the Numbers 2027 report. Five inflators drive the increase: AI-enabled tools that help providers capture more revenue (ranked a top-three inflator by 70% of health plans), rising provider reimbursement amid consolidation (hospital services inflation hit 7.59% year over year in February 2026), growing pharmacy spend (3.5 million GLP-1 prescriptions filled in December 2025, nearly double a year earlier), a 62.6% rise in behavioral health utilization from 2018 to 2024, and No Surprises Act arbitration, where providers win 88% of payment disputes. With external deflators largely exhausted, PwC argues payers must lean on benefit design, network design, and utilization management to bend the curve.

Why It Matters

For multi-site operators and PE-backed groups, a 9% cost trend signals tightening payer scrutiny on reimbursement and utilization — and rising employer-plan costs. The same AI revenue tools fueling the trend are becoming table stakes, while network and payment-integrity pressure will reshape contract negotiations.

medical cost trend payer cost management GLP-1 spending behavioral health utilization provider reimbursement no surprises act RCM automation

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Frequently asked questions

How high will medical cost trend be in 2027?

PwC projects commercial medical cost trend will reach 9% in 2027 — the highest level in 17 years. The Group market is projected at 9% and the Individual market at 8.5%, and PwC restated its 2026 trends upward to 9.0% and 8.5% respectively.

What is driving the 2027 healthcare cost increase?

Five inflators drive the trend: AI-enabled tools that help providers capture more revenue, provider reimbursement pressure amplified by consolidation, rising pharmacy spend led by GLP-1s, a 62.6% jump in behavioral health utilization since 2018, and No Surprises Act arbitration, where providers win 88% of disputes.

What can payers do to slow medical cost trend?

With external deflators like biosimilars and generics already baked into baselines, PwC says payers must use levers they control directly — benefit and formulary design, network design, utilization management, and claims and payment integrity. Network design and reimbursement are the strongest long-term levers for resetting the cost baseline.

Similar Posts

  • Agentic Engine Optimization: How to Restructure Healthcare Content for AI Agents

    Bypaulgruensfelder

    Agentic Engine Optimization (AEO) is the practice of structuring content so AI agents can fetch, parse, and act on it — not just render it for human readers. Google Cloud AI director Addy Osmani published a six-layer AEO framework in April 2026, advising publishers to restructure content for agent consumption across five dimensions: discoverability, parsability, token efficiency, capability signaling, and access control. Token count is now a core optimization metric — quick-start content should stay under roughly 15,000 tokens. Long or bloated pages risk truncation, skipping, or poor chunking by agents operating within limited context windows. Healthcare operators building content programs need to treat machine readability as a first-class signal alongside traditional SEO — the brands that structure service pages and clinical content for AI agent consumption will capture both organic rankings and AI-generated search citations ahead of competitors.

  • 6 Health Systems Outsourcing Revenue Cycle Functions in 2026

    Bypaulgruensfelder

    Six U.S. health systems—including IU Health, UnityPoint Health, and Stamford Health—moved revenue cycle functions to outside vendors in the first half of 2026, signaling that RCM outsourcing has become a core financial strategy rather than a last resort. IU Health partnered with Ensemble Health Partners on June 9, while UnityPoint shifted functions to Omega Healthcare amid rising labor, supply, and drug costs. Several deals transferred staff directly to vendors: Margaret Mary Health moved 53 employees to Revology, and Knox Community Hospital transferred 42 billing staff to Ovation Healthcare. The pattern reflects mounting margin pressure and a shift toward partners that promise end-to-end performance accountability and predictable cost structures.

  • Fullspan Health Launches Healthline AI Companion for Verified Health Answers

    Bypaulgruensfelder

    Healthline AI is a conversational AI agent launched by Fullspan Health in June 2026, designed to connect consumers to medically reviewed health information and provider recommendations. Unlike general-purpose large language models, the tool draws exclusively from Fullspan’s editorial properties—Healthline, Healthgrades, Medical News Today, and Psych Central—anchoring responses in more than two decades of clinical review standards. The initial release focuses on Type 2 diabetes, with plans to expand to additional conditions. The platform includes clinical guardrails: queries involving chest pain, severe mental distress, or self-harm are routed to emergency resources rather than answered. Providers are surfaced through Healthgrades integration, making the tool a potential new patient-acquisition channel for health systems and multi-site practices.

  • The De Novo Marketing Playbook for New Healthcare Locations

    Bypaulgruensfelder

    De novo healthcare locations routinely underperform in their first months because media plans launch too late—often just weeks before opening, when the algorithm still needs time to learn. Cardinal Digital Marketing’s Rich Briddock outlines a three-phase framework that starts with brand awareness campaigns 60–90 days before opening, shifts to conversion-focused media around launch day, and transitions to integrated multi-location account management by months two and three. The playbook emphasizes pre-launch tracking infrastructure, audience building for retargeting, and cannibalization monitoring when the new site is near an existing location. Groups that follow this sequence report fuller schedules on day one and cleaner performance data from week one forward.

  • 3 Investment Trends Shaping Behavioral Health Deals in 2026

    Bypaulgruensfelder

    Behavioral health M&A in 2026 is running slower than expected but deal activity continues. SUD treatment may be the most undervalued subsector, with deal flow at a six-year low yet clinically strong operators attracting renewed investor interest. Investors now require founders to retain equity and stay involved post-acquisition. With 90%+ of behavioral health still independently owned, consolidators see significant runway — if they can navigate Medicaid uncertainty from the One Big Beautiful Bill Act and exchange subsidy changes. Analysis from Lee Equity Partners, Mertz Taggart, and Beacon Behavioral Partners.

  • Dental M&A 2026: Ten Shifts DSO Leaders Must Understand Now

    Bypaulgruensfelder

    Dental M&A in 2026 has moved from growth at any cost to operational discipline, according to new data from TUSK Practice Sales. Although 69% of DSOs plan to increase acquisitions this year, a high-demand, low-supply market will make deals harder to close — TUSK expects this imbalance to persist for nine months. Several large DSOs, including Dental Care Alliance and Affordable Care, have transitioned into lender control following restructuring, signaling the limits of debt-fueled expansion. Meanwhile, private placement memorandum exits rose 57.1% last year, and 78% of DSOs anticipate recapitalization within 12–36 months. DSOs now require minimum 5-year post-close employment terms and are exiting deals over staffing and clinical continuity risks. The era of rapid network expansion is giving way to regional density, financial discipline, and technology investment.